Quadrature Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.96M | Buy |
+15,260
| New | +$1.79M | 0.02% | 508 |
|
|
2025
Q4 | – | Sell |
-13,128
| Closed | -$1.1M | – | 1523 |
|
|
2025
Q3 | $1.1M | Sell |
13,128
-5,409
| -29% | -$446K | 0.01% | 371 |
|
|
2025
Q2 | $1.47M | Sell |
18,537
-133,728
| -88% | -$10.6M | 0.03% | 349 |
|
|
2025
Q1 | $13.7M | Sell |
152,265
-9,955
| -6% | -$929K | 0.3% | 85 |
|
|
2024
Q4 | $16.1M | Sell |
162,220
-123,514
| -43% | -$12.7M | 0.32% | 74 |
|
|
2024
Q3 | $32.4M | Sell |
285,734
-19,405
| -6% | -$2.31M | 0.74% | 29 |
|
|
2024
Q2 | $37.8M | Buy |
305,139
+97,521
| +47% | +$12.6M | 0.63% | 42 |
|
|
2024
Q1 | $27.4M | Buy |
207,618
+103,944
| +100% | +$12.8M | 0.47% | 50 |
|
|
2023
Q4 | $11.3M | Buy |
+103,674
| New | +$10.8M | 0.2% | 88 |
|
|
2023
Q1 | – | Sell |
-3,988
| Closed | -$442K | – | 1092 |
|
|
2022
Q4 | $442K | Sell |
3,988
-54,332
| -93% | -$5.55M | 0.01% | 538 |
|
|
2022
Q3 | $5.03M | Sell |
58,320
-48,884
| -46% | -$4.36M | 0.16% | 145 |
|
|
2022
Q2 | $9.79M | Sell |
107,204
-28,052
| -21% | -$2.49M | 0.41% | 68 |
|
|
2022
Q1 | $11.1M | Buy |
135,256
+105,580
| +356% | +$8.32M | 0.45% | 61 |
|
|
2021
Q4 | $2.27M | Sell |
29,676
-156,485
| -84% | -$12.5M | 0.12% | 126 |
|
|
2021
Q3 | $14M | Buy |
+186,161
| New | +$14.2M | 0.51% | 51 |
|
|
2020
Q4 | – | Sell |
-53,595
| Closed | -$4.24M | – | 974 |
|
|
2020
Q3 | $4.24M | Buy |
+53,595
| New | +$4.2M | 0.24% | 112 |
|
|
2020
Q2 | – | Sell |
-7,662
| Closed | -$563K | – | 735 |
|
|
2020
Q1 | $563K | Buy |
+7,662
| New | +$602K | 0.13% | 210 |
|
|
2019
Q4 | – | Sell |
-6,917
| Closed | -$556K | – | 640 |
|
|
2019
Q3 | $556K | Buy |
+6,917
| New | +$554K | 0.03% | 372 |
|
|
2019
Q1 | – | Sell |
-9,226
| Closed | -$673K | – | 644 |
|
|
2018
Q4 | $673K | Sell |
9,226
-31,459
| -77% | -$2.22M | 0.12% | 202 |
|
|
2018
Q3 | $2.75M | Buy |
+40,685
| New | +$2.59M | 0.23% | 106 |
|
|
2018
Q2 | – | Sell |
-133,196
| Closed | -$6.92M | – | 641 |
|
|
2018
Q1 | $6.92M | Buy |
+133,196
| New | +$7.19M | 0.54% | 47 |
|
|
2017
Q3 | – | Sell |
-92,456
| Closed | -$5.65M | – | 564 |
|
|
2017
Q2 | $5.65M | Sell |
92,456
-68,999
| -43% | -$4.2M | 0.43% | 54 |
|
|
2017
Q1 | $9.79M | Buy |
+161,455
| New | +$9.8M | 0.7% | 32 |
|
|
2015
Q4 | – | Sell |
-6,183
| Closed | -$291K | – | 498 |
|
|
2015
Q3 | $291K | Buy |
+6,183
| New | +$328K | 0.1% | 220 |
|
Other funds holding MRK
Quadrature Capital's MRK Position: Q2 2026 in Review
Quadrature Capital opened a new position in Merck (MRK) in Q2 2026: 15,260 shares worth $1.96M. The stake represents 0.02% of the portfolio and ranks #508 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in MRK as recently as Q3 2025.
Quadrature Capital first reported a position in MRK in Q3 2015 and has held it in 24 quarters since. The position peaked at $37.8M in Q2 2024. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Quadrature Capital held 15,260 shares of Merck worth $1.96M as of Q2 2026.
- Merck was a new Quadrature Capital position in Q2 2026.
- Merck made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #508 holding.
- Quadrature Capital first reported a position in Merck in Q3 2015 and has held it in 24 quarters since.
- Quadrature Capital's Merck position peaked at $37.8M in Q2 2024.
- 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.